For instance, as mentioned in Table 3, pirfenidone counteracts the TGFβ bioavailability in patients with idiopathic pulmonary fibrosis, while vismodegib is the inhibitor for Hh signaling used in cancer treatment [84,151]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.